Form 4: Cardio Diagnostics Holdings Director Peter K Fung Reports Stock Option Transaction
SEC Form 4
Director Peter K Fung of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities.
Summary
- On March 31, 2025, Peter K Fung, a director of Cardio Diagnostics Holdings, Inc., reported a transaction involving stock options.
- Fung acquired 18,939 stock options with an exercise price of $0.33.
- The options are exercisable immediately and expire on March 31, 2035.
- Fung also disposed of 21,211 derivative securities.
- Following the reported transactions, Fung owns 21,211 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option transactions, which has a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency to investors regarding the holdings and transactions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director's holdings.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of earliest transaction: Acquisition of stock options and disposal of derivative securities. |
| 03/31/2025 | Date stock options are exercisable. |
| 03/31/2035 | Expiration date of the stock options. |
| 04/01/2025 | Date of report. |
Keywords
Form 4, Cardio Diagnostics Holdings, Stock Options, Director, Beneficial Ownership, CDIO, Peter K Fung
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.